Both genes and environment have been implicated in determining the complex body composition phenotypes in individuals of European ancestry; however, few studies have been conducted in other race/ethnic groups.
A dmixture mapping allows for the identification of chromosomal regions that influence complex phenotypes with variable incidence in different racial/ethnic groups (1) . In the United States, African-Americans (AAs) are particularly suited for admixture mapping because they comprise a diverse population who have admixed ancestry to varying degrees with other populations, including European-Americans.
Body composition phenotypes are particularly appealing for admixture mapping, given the well-established differences in bone mineral density (BMD) (2) and fat mass phenotypes (2) between AAs and European-Americans. This disparity coupled with literature showing correlations between global ancestry and body composition phenotypes (3, 4) lends support for a search for novel chro-mosomal regions/genes using an admixture mapping approach.
We hypothesized that BMD and fat mass phenotypes are associated with both global and local African ancestry proportions in AA women. To test these hypotheses, we performed an admixture mapping study in the Women's Health Initiative (WHI) single nucleotide polymorphism (SNP) Health Association Resource (SHARe).
Materials and Methods

WHI
The WHI SHARe has extensive phenotypic and genome-wide data on 8515 self-identifying AA postmenopausal women between 50 and 79 years of age at baseline randomly selected from 12 151 AA participants. Study protocols and consent forms were approved by the Institutional Review Boards at all participating institutions.
Genotyping
Genotyping was performed at Affymetrix Inc (Affymetrix, Santa Clara, California; www.affymetrix.com) using the Genome-Wide Human SNP Array 6.0 on DNA extracted from blood at the Fred Hutchinson Cancer Research Center. We removed SNPs that failed genotyping (Ͻ0.001%), call rates Ͻ95%, concordance rates Ͻ98%, and with minor allele frequency (MAF) Ͻ1%, leaving 855 034 SNPs for analysis.
Global ancestry estimation
Frappe (5) estimates of each individual's global ancestry were generated using 656 852 autosomal markers on 475 samples from the Human Genome Diversity project (6) representing African (Yoruban, YRI), Northern and Western European (CEU), East Asian (Han Chinese and Japanese from Tokyo), and Native American ancestry.
Local ancestry estimation
For each individual, we estimated locus-specific ancestry at 570 282 SNPs on the autosomal chromosomes applying an extension of the model in SABER software (7, 8) ; we used phased haplotype data from the HapMap3 CEU and YRI individuals as reference panels. We statistically replicated SABER estimates using approaches implemented in HAPMIX (9) and LAMP (10) . For the X chromosome, we derived HAPMIX-only estimates and considered LAMP estimates for statistical replication.
Imputation
Imputation was performed using MACH (11) 
Dual-energy X-ray absorptiometry (DXA) measures
Whole-body DXA scans were performed using the Hologic QDR scanners (QDR 2000, 2000ϩ, or 4500W; Hologic, Waltham, Massachusetts). Scans were rigorously monitored at 3 participating sites for quality.
BMD phenotypes include total body, total hip, trochanter, femoral neck, intertrochanter, and L2-L4 spine (g/cm 2 ). Fat mass phenotypes include whole-body, trunk fat mass (measured in grams), whole-body percentage fat mass, and ratio of trunk-towhole-body fat mass.
The DXA admixture study sample
In 842 of 8515 AA women, a DXA scan was performed at WHI baseline. Women were then excluded on the basis of estimated relatedness (n ϭ 12) and Ͻ15% estimated AA ancestry (n ϭ 12). For analyses of whole-body BMD we excluded those with hip or other replacements (n ϭ 20) and ever broken spine or hip (n ϭ 8), yielding n ϭ 774. Due to missingness, femoral neck BMD sample size was 802 and L2-L4 spine sample included 782 women. The sample size for all fat mass analyses was 802.
Descriptive analyses
We estimated numerous descriptive statistics for relevant variables and Pearson correlation coefficients between all DXA phenotypes and global African ancestry adjusted for age and geographic region. We selected WHI covariates for final models using univariate regression models and t tests. Covariates in final fat mass models include age at menopause, metabolic equivalents (MET)-hours per week of exercise from walking, hormone therapy use, ever smoker, height, weight, study site, and global ancestry. BMD models include age, study site, age at menopause, lifetime hormone therapy duration, log-transformed body mass index, height, MET-hours per week due to moderate exercise and global ancestry. Models assessing L2-L4 spine BMD variation also included fracture at age 55 or older.
Admixture mapping analyses
Fine mapping
We performed genetic association testing for regions identified via admixture mapping using genotypes from the Affymetrix 6.0 array and imputed data. For genotyped SNPs we used linear regression models adjusted for the same covariates used for admixture mapping. For analyses of imputed SNPs, dosage data were used to account for uncertainty.
Results
Several characteristics differ by site according to the covariates analyzed, including proportion of global ancestry (Table 1 ). All hip BMD measures (total, femoral neck, trochanter, and intertrochanter) were highly correlated (0.81-0.88), as were measures of hip with L2-L4 BMD (0.67-0.68). There are statistically significant positive correlations between global African ancestry and all BMD phenotypes r Ͼ 0.10, all P Ͻ .012. Similarly, whole-body and trunk fat mass were positively correlated with global African ancestry (0.06 Ͻ r Ͻ 0.12; all P Ͻ .04).
BMD admixture mapping
Correlations between SABER, LAMP, and HAPMAX were excellent (r Ͼ 0.98); we therefore report on results of SABER only for autosomal chromosomes and HAPMIX for chromosome X. Femoral neck BMD was the only phenotype that reached genome-wide (admixture) significance (P Ͻ 1.5 ϫ 10 Ϫ5 ) ( ).
BMD fine mapping
Our 3 most significant genotype associations with femoral neck BMD are rs7250326 (P ϭ 3.6 ϫ 10 Ϫ6 ), rs2293166 (P ϭ 3.7 ϫ 10 Ϫ6 ), and rs13343790 (P ϭ 5.8 ϫ 10
Ϫ6
) located on 19q13 at 49700082 bp, 49696663 bp, and 45013678 bp, respectively. The rs7250326 SNP was genotyped, whereas the latter 2 SNPs were imputed (r 2 for imputation quality was 0.92). For all 3 genetic associations, we found that as the number of minor alleles increases femoral neck BMD increases by approximately 0.03 g/cm 2 . On average, the reference allele frequency for these 3 SNPs differs between YRI and CEU by 25%. The strongest L2-L4 BMD-genetic association on chromosome 13 (P ϭ 1.5 ϫ 10
Ϫ5
) was rs4884565 at 63724687 bp; the MAF at this SNP differs by Ͼ40% between YRI and CEU.
Fat mass admixture mapping and fine mapping
No fat mass phenotypes reached genome-wide significance. The most significant signals identified were that of (Table 2) . Our most significant fine mapping association with fat mass (rs5939379) was observed on chromosome X at 2793776 bp (P Ͻ 3 ϫ 10 Ϫ4 ). The MAF at this SNP differs by Ͼ80% between YRI and CEU.
Discussion
Previous studies demonstrated a relationship of global ancestry with DXA-derived phenotypes; however, to our knowledge, we have completed the only genome-wide admixture scan of DXA-derived phenotypes in an AA sample. Our findings suggest higher femoral neck BMD is associated with higher levels of African ancestry in a region on chromosome 19 and potentially chromosome 13. Suggestive associations for fat mass were identified on chromosomes X and 12.
To date, linkage and association studies have included primarily individuals of European ancestry. One linkage study showed significant evidence for cosegregation in our chromosome 19 region with osteoarthritis (13) and a recent genome-wide association study (GWAS) meta-analysis identified a novel signal for lumbar spine BMD (and a lesser association with femoral neck BMD) near the boundary of our 19q region (14) . Although the association of African ancestry and L2-L4 spine BMD on 13q21 did not meet strict genome-wide significance, genetic association with femoral neck BMD was reported in this region (15) .
The rs2293166 BMD SNP is an expression quantitative trait locus (eQTL) for ZNF180 (16) , which is expressed in bone (17) . Several transcription factors in different cell lines and multiple histone marks overlap the region containing rs2293166, and this SNP is contained within a deoxyribonuclease l (DNasel) hypersensitivity site. The rs7250326 SNP also sits on a histone mark (H3K27AC) and is an open chromatin region, implying potential for this SNP to serve a regulatory role (18) . Given the genetic features associated with these SNPs, it is possible that they affect transcription factor binding in this area.
Our fat mass associations were not significant genomewide but we present the 12p12 findings in light of 2 obesity GWAS that identified a SNP (rs718314) approximately 2 MB from our ratio of trunk:whole-body fat mass peak (19, 20) . Another GWAS meta-analysis reported an association of rs6487924 in IPO8 with abdominal obesity phenotypes at 12p11.21 (21) .
Admixture mapping using a dense panel of markers in AAs is known to require fewer samples and the conduct of fewer independent tests relative to GWAS (22) . Despite our relatively modest sample size, the admixture mapping approach and the distribution of our quantitative phenotype in the two populations offered our study 80% power to detect variants contributing as little as 2.5% to phenotypic variation. We were able to identify a statistically significant association of femoral neck BMD and African ancestry on chromosome 19q13. The overlap of significant regions and genetic variants from published studies to date on top of our results provide further impetus for more fine mapping and replication studies. The primary strengths of our study are the unique WHI SHARe population with detailed epidemi- ologic and demographic information on a group of wellcharacterized AA women coupled with the availability of a large number of markers for admixture mapping. In summary, using a genome-wide admixture approach in 842 AA women from WHI SHARe, we detected 2 novel regions on chromosome 19 associated with femoral neck BMD and near significant associations with fat mass. The new information coming from our study suggests that ancestry may be an important modifier of the genetic associations with complex phenotypes associated with this genomic region and should be carefully studied further with regard to pleiotropic effects that may exist.
